Novai Publishes Study Supporting Use of DARC Imaging Technology to Identify Patients at Risk of Central Vision Loss From Macular Atrophy
Novai, a medtech company pioneering earlier detection and intervention for eye and brain diseases, today announced publication of a peer-reviewed study in Expert Review of Ophthalmology supporting its Detection of Apoptosing Retinal Cells (DARC) imaging technology as a promising biomarker for identifying patients at risk of central vision loss from macular atrophy (MA), an advanced form of age-related macular degeneration and a major cause of irreversible vision loss.
